NEXTEDIA (ALNXT.PA) Fundamental Analysis & Valuation

EPA:ALNXT • FR0004171346

0.396 EUR
0 (-0.5%)
Last: Mar 12, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This ALNXT.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

ALNXT gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 75 industry peers in the IT Services industry. While ALNXT seems to be doing ok healthwise, there are quite some concerns on its profitability. A decent growth rate in combination with a cheap valuation! Better keep an eye on ALNXT.


Dividend Valuation Growth Profitability Health

3

1. ALNXT.PA Profitability Analysis

1.1 Basic Checks

  • In the past year ALNXT was profitable.
  • In the past year ALNXT had a positive cash flow from operations.
  • In the past 5 years ALNXT has always been profitable.
  • ALNXT had a positive operating cash flow in 4 of the past 5 years.
ALNXT.PA Yearly Net Income VS EBIT VS OCF VS FCFALNXT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M 8M

1.2 Ratios

  • With a Return On Assets value of 2.83%, ALNXT perfoms like the industry average, outperforming 41.33% of the companies in the same industry.
  • ALNXT has a worse Return On Equity (4.93%) than 61.33% of its industry peers.
  • With a Return On Invested Capital value of 6.30%, ALNXT perfoms like the industry average, outperforming 44.00% of the companies in the same industry.
  • ALNXT had an Average Return On Invested Capital over the past 3 years of 6.20%. This is below the industry average of 11.13%.
  • The last Return On Invested Capital (6.30%) for ALNXT is above the 3 year average (6.20%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.83%
ROE 4.93%
ROIC 6.3%
ROA(3y)2.64%
ROA(5y)3.08%
ROE(3y)5.31%
ROE(5y)6.42%
ROIC(3y)6.2%
ROIC(5y)6.1%
ALNXT.PA Yearly ROA, ROE, ROICALNXT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

1.3 Margins

  • Looking at the Profit Margin, with a value of 2.50%, ALNXT is in line with its industry, outperforming 44.00% of the companies in the same industry.
  • ALNXT's Profit Margin has declined in the last couple of years.
  • The Operating Margin of ALNXT (5.15%) is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of ALNXT has declined.
  • Looking at the Gross Margin, with a value of 54.19%, ALNXT is doing worse than 60.00% of the companies in the same industry.
  • ALNXT's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 5.15%
PM (TTM) 2.5%
GM 54.19%
OM growth 3Y-10.16%
OM growth 5Y-2.26%
PM growth 3Y-8.02%
PM growth 5Y-2.63%
GM growth 3Y-8.46%
GM growth 5Y-11.02%
ALNXT.PA Yearly Profit, Operating, Gross MarginsALNXT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. ALNXT.PA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ALNXT is destroying value.
  • The number of shares outstanding for ALNXT remains at a similar level compared to 1 year ago.
  • ALNXT has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for ALNXT has been reduced compared to a year ago.
ALNXT.PA Yearly Shares OutstandingALNXT.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
ALNXT.PA Yearly Total Debt VS Total AssetsALNXT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • ALNXT has an Altman-Z score of 2.12. This is not the best score and indicates that ALNXT is in the grey zone with still only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.12, ALNXT is in line with its industry, outperforming 44.00% of the companies in the same industry.
  • ALNXT has a debt to FCF ratio of 3.10. This is a good value and a sign of high solvency as ALNXT would need 3.10 years to pay back of all of its debts.
  • ALNXT's Debt to FCF ratio of 3.10 is in line compared to the rest of the industry. ALNXT outperforms 57.33% of its industry peers.
  • A Debt/Equity ratio of 0.12 indicates that ALNXT is not too dependend on debt financing.
  • With a decent Debt to Equity ratio value of 0.12, ALNXT is doing good in the industry, outperforming 78.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 3.1
Altman-Z 2.12
ROIC/WACC0.93
WACC6.75%
ALNXT.PA Yearly LT Debt VS Equity VS FCFALNXT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

  • A Current Ratio of 1.25 indicates that ALNXT should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.25, ALNXT is in line with its industry, outperforming 53.33% of the companies in the same industry.
  • A Quick Ratio of 1.25 indicates that ALNXT should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.25, ALNXT is in line with its industry, outperforming 60.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.25
Quick Ratio 1.25
ALNXT.PA Yearly Current Assets VS Current LiabilitesALNXT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. ALNXT.PA Growth Analysis

3.1 Past

  • ALNXT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 48.13%, which is quite impressive.
  • The Earnings Per Share has been growing slightly by 3.66% on average over the past years.
  • Looking at the last year, ALNXT shows a decrease in Revenue. The Revenue has decreased by -2.25% in the last year.
  • ALNXT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 21.48% yearly.
EPS 1Y (TTM)48.13%
EPS 3Y-3.66%
EPS 5Y3.66%
EPS Q2Q%4.76%
Revenue 1Y (TTM)-2.25%
Revenue growth 3Y8.74%
Revenue growth 5Y21.48%
Sales Q2Q%-8.17%

3.2 Future

  • The Earnings Per Share is expected to grow by 9.47% on average over the next years. This is quite good.
  • ALNXT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.18% yearly.
EPS Next Y20.64%
EPS Next 2Y9.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year13.87%
Revenue Next 2Y8.18%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALNXT.PA Yearly Revenue VS EstimatesALNXT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
ALNXT.PA Yearly EPS VS EstimatesALNXT.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2022 2023 2024 2025 2026 0.02 0.04 0.06 0.08

More info and screens

Find the best growth stocksShow best growing peers

7

4. ALNXT.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 9.90 indicates a reasonable valuation of ALNXT.
  • ALNXT's Price/Earnings ratio is rather cheap when compared to the industry. ALNXT is cheaper than 90.67% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of ALNXT to the average of the S&P500 Index (25.71), we can say ALNXT is valued rather cheaply.
  • With a Price/Forward Earnings ratio of 4.27, the valuation of ALNXT can be described as very cheap.
  • Based on the Price/Forward Earnings ratio, ALNXT is valued cheaper than 94.67% of the companies in the same industry.
  • ALNXT is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.82, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 9.9
Fwd PE 4.27
ALNXT.PA Price Earnings VS Forward Price EarningsALNXT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 76.00% of the companies in the same industry are more expensive than ALNXT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 8.46
EV/EBITDA N/A
ALNXT.PA Per share dataALNXT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.48
PEG (5Y)2.7
EPS Next 2Y9.47%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALNXT.PA Dividend Analysis

5.1 Amount

  • ALNXT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALNXT.PA Fundamentals: All Metrics, Ratios and Statistics

NEXTEDIA

EPA:ALNXT (3/12/2026, 7:00:00 PM)

0.396

0 (-0.5%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners17.68%
Ins Owner ChangeN/A
Market Cap15.45M
Revenue(TTM)62.04M
Net Income(TTM)1.55M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 9.9
Fwd PE 4.27
P/S 0.25
P/FCF 8.46
P/OCF 8.08
P/B 0.49
P/tB 13.33
EV/EBITDA N/A
EPS(TTM)0.04
EY10.1%
EPS(NY)0.09
Fwd EY23.41%
FCF(TTM)0.05
FCFY11.82%
OCF(TTM)0.05
OCFY12.37%
SpS1.59
BVpS0.81
TBVpS0.03
PEG (NY)0.48
PEG (5Y)2.7
Graham Number0.85
Profitability
Industry RankSector Rank
ROA 2.83%
ROE 4.93%
ROCE 8.85%
ROIC 6.3%
ROICexc 7.81%
ROICexgc N/A
OM 5.15%
PM (TTM) 2.5%
GM 54.19%
FCFM 2.94%
ROA(3y)2.64%
ROA(5y)3.08%
ROE(3y)5.31%
ROE(5y)6.42%
ROIC(3y)6.2%
ROIC(5y)6.1%
ROICexc(3y)8.02%
ROICexc(5y)8.4%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.71%
ROCE(5y)8.58%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-9.69%
ROICexc growth 5Y-0.48%
OM growth 3Y-10.16%
OM growth 5Y-2.26%
PM growth 3Y-8.02%
PM growth 5Y-2.63%
GM growth 3Y-8.46%
GM growth 5Y-11.02%
F-Score7
Asset Turnover1.13
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 3.1
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.14%
Interest Coverage 250
Cash Conversion N/A
Profit Quality 117.82%
Current Ratio 1.25
Quick Ratio 1.25
Altman-Z 2.12
F-Score7
WACC6.75%
ROIC/WACC0.93
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.47%
Cap/Sales(5y)0.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)48.13%
EPS 3Y-3.66%
EPS 5Y3.66%
EPS Q2Q%4.76%
EPS Next Y20.64%
EPS Next 2Y9.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.25%
Revenue growth 3Y8.74%
Revenue growth 5Y21.48%
Sales Q2Q%-8.17%
Revenue Next Year13.87%
Revenue Next 2Y8.18%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y5.19%
EBIT growth 3Y-2.31%
EBIT growth 5Y18.73%
EBIT Next Year22.44%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-22.15%
FCF growth 3Y-11.08%
FCF growth 5YN/A
OCF growth 1Y-33.49%
OCF growth 3Y-10.82%
OCF growth 5YN/A

NEXTEDIA / ALNXT.PA FAQ

Can you provide the ChartMill fundamental rating for NEXTEDIA?

ChartMill assigns a fundamental rating of 5 / 10 to ALNXT.PA.


What is the valuation status of NEXTEDIA (ALNXT.PA) stock?

ChartMill assigns a valuation rating of 7 / 10 to NEXTEDIA (ALNXT.PA). This can be considered as Undervalued.


What is the profitability of ALNXT stock?

NEXTEDIA (ALNXT.PA) has a profitability rating of 3 / 10.


How financially healthy is NEXTEDIA?

The financial health rating of NEXTEDIA (ALNXT.PA) is 5 / 10.